tiprankstipranks

Marc Tessier-Lavigne Insider Profile

4 Followers
Marc Tessier-Lavigne, Director at Juno Therapeutics, holds 2.11M shares in Denali Therapeutics (Ticker: DNLI), holds 2.43K shares in Regeneron (Ticker: REGN), holds 250.00K shares in Juno Therapeutics (Ticker: JUNO).
tipranks
Marc Tessier-Lavigne

Marc Tessier-Lavigne
Juno Therapeutics (JUNO)
Director

Ranked #14,951 out of 97,825 Corporate Insiders

Profitable Transactions

78%
7 out of 9 Profitable Transactions

Average Return

+11.30%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$49M
89.23%
5.98%
4.79%
0.00%
A breakdown of Marc Tessier-Lavigne's holdings

Insider Roles

Denali Therapeutics
(DNLI)
Director
Agios Pharma
(AGIO)
Director
Regeneron
(REGN)
Director
Pfizer
(PFE)
Director
Roles that Marc Tessier-Lavigne holds in companies

Most Profitable Insider Trade

Stock:
Agios Pharma
(AGIO)
Rating:Informative Buy
Date:Apr 03, 2014 - Apr 03, 2015
Return:+168.30%
The most profitable trade made by Marc Tessier-Lavigne

Marc Tessier-Lavigne's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
JUNO
Juno Therapeutics
Dec 23, 2014
Uninformative Buy
$21.74M
Denali Therapeutics
Jun 05, 2023
Director
Uninformative Buy
$43.85M
Agios Pharma
Apr 03, 2014
Director
Informative Buy
999.99K
$2.94M
Regeneron
Jan 05, 2023
Director
Uninformative Buy
$2.35M
Pfizer
Director
$0.00
List of latest transactions for each holding click on a transaction to see Marc Tessier-Lavigne's performance on stock

Marc Tessier-Lavigne insider profile FAQ

What is the percentage of profitable transactions made by Marc Tessier-Lavigne?
The percentage of profitable transactions made by Marc Tessier-Lavigne is 78%.
    What is the average return per transaction made by Marc Tessier-Lavigne?
    The average return per transaction made by Marc Tessier-Lavigne is 11.30%.
      What stocks does Marc Tessier-Lavigne hold?
      Marc Tessier-Lavigne holds: JUNO, DNLI, AGIO, REGN, PFE stocks.
        What was Marc Tessier-Lavigne’s latest transaction?
        Marc Tessier-Lavigne latest transaction was an Uninformative Buy of ―.
          What was Marc Tessier-Lavigne's most profitable transaction?
          Marc Tessier-Lavigne’s most profitable transaction was an Informative Buy of AGIO stock on April 3, 2014. The return on the trade was 168.30%.
            What is Marc Tessier-Lavigne's role in Juno Therapeutics?
            Marc Tessier-Lavigne's role in Juno Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.